rs81002798

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1_ModeratePS3PM2PP5_Very_Strong

The NM_000059.4(BRCA2):​c.8487+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,457,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000186016: Multiple splicing assays have shown that this alteration leads to complete skipping of coding exon 18, resulting in a predicted in-frame deletion of 52 amino acid residues in a functionally important region of the BRCA2 protein (Ambry internal data" and additional evidence is available in ClinVar. The gene BRCA2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

BRCA2
NM_000059.4 splice_donor, intron

Scores

5
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic reviewed by expert panel P:17O:1

Conservation

PhyloP100: 9.92

Publications

24 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.015209125 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PS3
PS3 evidence extracted from ClinVar submissions: SCV000186016: Multiple splicing assays have shown that this alteration leads to complete skipping of coding exon 18, resulting in a predicted in-frame deletion of 52 amino acid residues in a functionally important region of the BRCA2 protein (Ambry internal data; Mesman RLS et al. Genet Med 2020 08;22(8):1355-1365; Chen X et al. Hum. Mutat. 2006 May;27:427-35; Acedo A et al. Breast Cancer Res. 2012 May 25;14:R87; Agata S et al. Cancer Genet. Cytogenet. 2003 Mar;141:175-6).; SCV000689129: Functional RNA studies have shown that this variant results in the skipping of exon 19, causing an in-frame deletion of 52 amino acids within the essential DNA binding domain of BRCA2 protein (PMID: 12606139, 16619214, 22632462).; SCV002049292: Functional assays demonstrate skipping of exon 19 (Agata 2003, Chen 2006). PMID: 12606139. PMID: 16619214.; SCV000073547: Studies have shown that disruption of this splice site results in skipping of exon 19, but is expected to preserve the integrity of the reading-frame (PMID: 12606139, 16619214, 22632462; internal data).; SCV000271334: "In vitro functional studies provide evidence that the c.8487+1G>A variant impacts splicing (Agata 2003, Acedo 2012, Chen 2006)."; SCV000918865: The variant was supported by experimental evidence which causes skipping of exon 19 leading to an abnormal protein product (p.Ille2778_Gln2829del)(Chen_2006, Agata_2003).
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-32370558-G-A is Pathogenic according to our data. Variant chr13-32370558-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 52602.Status of the report is reviewed_by_expert_panel, 3 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.8487+1G>A
splice_donor intron
N/ANP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.8487+1G>A
splice_donor intron
N/ANP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.8487+1G>A
splice_donor intron
N/ANP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.8487+1G>A
splice_donor intron
N/AENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.8487+1G>A
splice_donor intron
N/AENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.8118+1G>A
splice_donor intron
N/AENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.86e-7
AC:
1
AN:
1457402
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
725408
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33368
American (AMR)
AF:
0.00
AC:
0
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86150
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1107964
Other (OTH)
AF:
0.00
AC:
0
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
-
-
Breast-ovarian cancer, familial, susceptibility to, 2 (6)
4
-
-
Hereditary breast ovarian cancer syndrome (4)
3
-
-
Hereditary cancer-predisposing syndrome (3)
3
-
-
not provided (3)
1
-
-
Familial cancer of breast (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.44
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
32
DANN
Uncertain
1.0
Eigen
Pathogenic
1.2
Eigen_PC
Pathogenic
1.0
FATHMM_MKL
Pathogenic
0.99
D
PhyloP100
9.9
GERP RS
5.2
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
Splicevardb
3.0
SpliceAI score (max)
0.96
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.96
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs81002798; hg19: chr13-32944695; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.